Skip to main content
Log in

Antithrombotic Activity of a Novel Diazepino[1,2-α] Benzimidazole Derivative on Arterial Thrombosis Model in Rats without Concomitant Pathology and in Rats with Experimental Myocardial Infarction

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Antithrombotic activity of a novel tricyclic derivative of diazepino[1,2-α]benzimidazole (DAB-15) was examined on the model of arterial thrombosis developed in rats without concomitant pathology and in rats with experimental myocardial infarction. DAB-15 demonstrated high antithrombotic efficacy in modeled thrombosis of carotid artery in rats without the concomitant pathology surpassing that of the reference drugs acetylsalicylic acid and clopidogrel by 5.1 and 4.8 times, respectively. In rats with experimental noncoronary myocardial infarction, DAB-15 increased the thrombus formation time by 86.2% in comparison with experimental control level in non-treated rats with similar myocardial infarction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anisimova VA, Spasov AA, Ostrovskii OV, Dudchenko GP, Kosolapov VA, Kucheryavenko AF, Larionov NP, Kovalev SG. Synthesis and pharmacological activity of 3-aroyl- and 3-hetaroylimidazo[1,2-a] benzimidazoles. Pharm. Chem. J. 2002;36(12):637-642.

    Article  CAS  Google Scholar 

  2. Kucheryavenko AF, Anisimova VA, Gaidukova KA, Divaeva LN, Kuz’menko TA, Morkovnik AS, Sirotenko VS, Spasov AA. Antiaggregant Activity of a New Tricyclic Benzimidazole Derivative. Eskp. Klin. Farmakol. 2016;79(5):29-32. Russian.

    CAS  Google Scholar 

  3. Makarov VA, Spasov AA, Plotnikov MB, Belozerskaya GG, Vasil’eva TM, Drozd NN, Svistunov AA, Kucheryavenko AF, Malykhina LS, Naumenko LV, Nevedova OE, Petrukhina N, Aliev OI, Plotnikova TM. Methodical Recommendations for Evaluation of Drugs Affecting Hemostasis. Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. P. 453-479. Russian.

  4. Spasov AA, Dudchenko GP, Gavrilova ES, Kucheryavenko AF, Smirnova LA, Belabolkin MI, Anisimova VA, Vdovina GP. Diabenol, a new antidiabetic substance with hemobiological properties. Vestn. Volgograd. Gos. Med. Univer. 1997;52(3):47-51. Russian.

    Google Scholar 

  5. Tanashyan MM, Shabalina AA, Antonova KV, Maksimova MYu, Kostyreva MV, Nikonov AA, Romantsova TI. Hemostasis changes in ischemic stroke: role of chronic hyperglycemia. Tromboz, Gemostaz, Reologiya. 2017;69(1):21-26Russian.

    Google Scholar 

  6. García-Rayado G, Sostres C, Lanas A. Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. Expert. Rev. Clin. Pharmacol. 2017;10(8):875-888.

    Article  CAS  PubMed  Google Scholar 

  7. Jones WS, Patel MR. Antithrombotic therapy in peripheral artery disease: generating and translating evidence into practice. J. Am. Coll. Cardiol. 2018;71(3):352-362.

    Article  PubMed  Google Scholar 

  8. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb. Res. 1990;60(4):269-280.

    Article  CAS  PubMed  Google Scholar 

  9. Lavie CJ, Howden CW, Scheiman J, Tursi J. Upper gastrointestinal toxicity associated with long-term aspirin therapy: consequences and prevention. Curr. Probl. Cardiol. 2017;42(5):146-164.

    Article  PubMed  Google Scholar 

  10. Mohamed AR, El-Hadidy WF, Mannaa HF. Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats. Drugs R D. 2014;14(4):233-239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Nairooz R, Valgimigli M, Rochlani Y, Pothineni NV, Raina S, Sardar P, Mukherjee D, Naidu SS, Shavelle DM. Metaanalysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. Int. J. Cardiol. 2017;229:82-89.

    Article  PubMed  Google Scholar 

  12. Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197-210.

    Article  PubMed  Google Scholar 

  13. Spasov AA, Kucheryavenko AF, Kosolapov VA, Anisimova VA. Antithrombogenic activity of antioxidant compounds. Bull. Exp. Biol. Med. 2013;155(6):775-777.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. F. Kucheryavenko.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 12, pp. 710-713, December, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spasov, A.A., Kucheryavenko, A.F., Sirotenko, V.S. et al. Antithrombotic Activity of a Novel Diazepino[1,2-α] Benzimidazole Derivative on Arterial Thrombosis Model in Rats without Concomitant Pathology and in Rats with Experimental Myocardial Infarction. Bull Exp Biol Med 166, 747–750 (2019). https://doi.org/10.1007/s10517-019-04432-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04432-0

Key Words

Navigation